Bevacizumab and diarrhoea 
Bevacizumab and diarrhoea Patient Reports March 20, 2010
Bevacizumab Side Effects Report #5765289-5
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on June 09, 2008. Female patient, weighting 101.4 lb, was diagnosed with renal cell carcinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain
, diarrhoea, hypertension, hypothyroidism, nausea . Bevacizumab dosage: 15 MG/KG (690 MG) Q 21 DAYS IV. During the same period patient was treated with BORTEZOMIB. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5852385-7
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Aug 20, 2008. Male patient, weighting 114.2 lb, was diagnosed with renal cell carcinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain
, chest pain , chronic obstructive pulmonary disease, diarrhoea, metastasis. Bevacizumab dosage: 15 MG/KG (777MG) Q 21 DAYS IV. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5317435-5
Bevacizumab side effect was reported by a Physician from UNITED STATES on May 03, 2007. Female patient, 49 years of age, weighting 135.0 lb, was diagnosed with rectal cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain
, chapped lips, cheilitis, diarrhoea, enteritis, flatulence, heart rate increased, lip dry, nausea . Bevacizumab dosage: 5MG/KG IV. During the same period patient was treated with OXALIPLATIN, LEUCOVORIN, FLUOROURACIL. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5321887-4
Bevacizumab side effect was reported by a Physician from UNITED STATES on May 02, 2007. Female patient, 49 years of age, weighting 135.0 lb, was diagnosed with rectal cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: diarrhoea, enteritis. Bevacizumab dosage: 5 MG/KG, UNK. During the same period patient was treated with OXALIPLATIN, LEUCOVORIN CALCIUM, FLUOROURACIL. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5775678-0
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on June 02, 2008. Male patient, weighting 119.5 lb, was diagnosed with rectal cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: diarrhoea, gastrointestinal mucosal disorder. Bevacizumab dosage: 270 MG, Q2W. During the same period patient was treated with IRINOTECAN. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5792534-2
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on June 12, 2008. Male patient, weighting 119.5 lb, was diagnosed with rectal cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: diarrhoea, gastrointestinal inflammation. Bevacizumab dosage: 270 MG, QD. During the same period patient was treated with IRINOTECAN, DEXAMETHASONE, KYTRIL, HANGE. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5043213-0
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on July 03, 2006. Male patient, weighting 176.0 lb, was diagnosed with pancreatic neoplasm and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain
, diarrhoea, dyspnoea, enteritis, febrile neutropenia, pyrexia, small intestinal obstruction. Bevacizumab dosage: 400 MG QS Q2WEEKS IV. During the same period patient was treated with DEXAMETHASONE, LORAZEPAM, GRANISETRON, OXALIPLATIN, LEUCOVORIN CALCIUM, FLUOROURACIL, VICODIN, IMODIUM. Patient recovered.Bevacizumab Side Effects Report #5082186-1
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Aug 15, 2006. Male patient, weighting 176.0 lb, was diagnosed with pancreatic neoplasm and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: diarrhoea, enteritis, febrile neutropenia, small intestinal obstruction. Bevacizumab dosage: 400 MG GE Q 2 WEEKS IV. During the same period patient was treated with OXALIPLATIN, LEUCOVORIN, VICODIN, IMODIUM, ATIVAN, LISONOPRIL, NORVASC. Patient recovered.
Bevacizumab Side Effects Report #5008454-7
Bevacizumab side effect was reported by a Physician from UNITED STATES on May 22, 2006. Male patient, weighting 250.0 lb, was diagnosed with pancreatic neoplasm and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain upper, chills, dehydration, diarrhoea, fatigue, flatulence, hypoaesthesia, hypotension. Bevacizumab dosage: 570 MG QS Q2 WKS. During the same period patient was treated with DEXAMETHASONE, LORAZEPAM, GRANISETRON, OXALIPLATIN, LEUCOVORIN CALCIUM, FLUOROURACIL, PROTONIX, SANDOSTATIN LAR. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #4764612-8
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Aug 19, 2005. Female patient, 71 years of age, weighting 123.0 lb, was diagnosed with ovarian cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: blood sodium decreased, culture positive, decreased appetite, diarrhoea, enteritis, enterococcal infection, gastric dilatation, gastrointestinal perforation, haematocrit decreased. Bevacizumab dosage: 840 MG, Q3W, INTRAVENOUS. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #4905345-4
Bevacizumab side effect was reported by a Physician from UNITED STATES on Jan 20, 2006. Female patient, 39 years of age, weighting 226.9 lb, was diagnosed with ovarian cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain
, abdominal pain lower, anal fistula, body temperature increased, decreased appetite, diarrhoea, heart rate increased, nausea . Bevacizumab dosage: unknown. During the same period patient was treated with IRINOTECAN, FLUOROURACIL, LEUCOVORIN CALCIUM, ASPIRIN, ATIVAN, LIPITOR, LOPRESSOR. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5751097-8
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on May 13, 2008. Female patient was diagnosed with ovarian cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: adhesion
, anastomotic leak, clostridium difficile colitis, diarrhoea, enterocutaneous fistula, intestinal gangrene, intestinal ischaemia, intestinal obstruction, pelvic abscess. Bevacizumab dosage: 450 MG, Q3W. During the same period patient was treated with PACLITAXEL, CARBOPLATIN, LISINOPRIL, ACETAMINOPHEN, LANSOPRAZOLE. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5447680-X
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Sept 06, 2007. Male patient, 75 years of age, weighting 113.8 lb, was diagnosed with oesophageal carcinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: dehydration, diarrhoea, febrile neutropenia. Bevacizumab dosage: 10MG/KG DAY 1 Q 3 WEEKS IV (C1+C2). During the same period patient was treated with DOCETAXEL, IRINOTECAN. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5386875-0
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on July 05, 2007. Female patient, weighting 94.98 lb, was diagnosed with oesophageal carcinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: dehydration, diarrhoea, hypomagnesaemia, hypophosphataemia, vomiting. Bevacizumab dosage: 10 MG/M2, UNK. During the same period patient was treated with DOCETAXEL, CISPLATIN, IRINOTECAN, ATENOLOL, COMPAZINE, FENTANYL TRANSDERMAL SYSTEM, MAALOX FAST BLOCKER, TYLENOL. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5391553-8
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on July 12, 2007. Female patient, weighting 94.98 lb, was diagnosed with oesophageal carcinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: candidiasis, dehydration, diarrhoea, hypomagnesaemia, hypophosphataemia, vomiting. Bevacizumab dosage: 10 MG/M2, UNK. During the same period patient was treated with DOCETAXEL, CISPLATIN, IRINOTECAN, ATENOLOL, COMPAZINE, FENTANYL, MAALOX FAST BLOCKER, TYLENOL. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #6042375-6
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Jan 12, 2009. Male patient, weighting 186.0 lb, was diagnosed with oesophageal carcinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: diarrhoea, dysphagia, febrile neutropenia, vomiting. Bevacizumab dosage: 15 MG/KG, DAYS 1+22. During the same period patient was treated with ERLOTINIB, PACLITAXEL, CARBOPLATIN, FLUOROURACIL. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5300838-2
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Apr 17, 2007. Male patient, 75 years of age, weighting 196.2 lb, was diagnosed with non-small cell lung cancer, bone marrow failure and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: asthenia, cough, decubitus ulcer, deep vein thrombosis
, diarrhoea, haemoglobin decreased, hyperhidrosis, lung infiltration, oxygen saturation decreased. Bevacizumab dosage: 15 MG/KG, Q3W. During the same period patient was treated with TAXOTERE, OXALIPLATIN, DILAUDID, FILGRASTIM, DURAGESIC, TUSSINEX, PHENERGAN, HYCODAN. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5471951-4
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Sept 14, 2007. Male patient, weighting 145.5 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anorexia, diarrhoea, fatigue, pyrexia. Bevacizumab dosage: 960 MG, UNK. During the same period patient was treated with PACLITAXEL, CARBOPLATIN. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5536094-X
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Nov 23, 2007. Male patient, weighting 116.8 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: blood chloride decreased, blood potassium decreased, blood sodium decreased, diarrhoea, platelet count decreased, white blood cell count decreased. Bevacizumab dosage: 800 MG, Q3W. During the same period patient was treated with PREDNISOLONE, VINORELBINE, CISPLATIN, DEXAVENT, SYNCUMAR, CODEINE SUL, THIOCODIN, LANSOPRAZOLE. Patient was hospitalized. Patient died on 10/19/2007.
Bevacizumab Side Effects Report #5651514-8
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Feb 21, 2008. Male patient, weighting 138.9 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: diarrhoea, epistaxis, nausea
. Bevacizumab dosage: 1050 MG, Q3W. During the same period patient was treated with CARBOPLATIN, GEMCITABINE, CHLORPHENAMINE, CYCLIZINE, CODEINE SUL, ACETAMINOPHEN. Patient died.Bevacizumab Side Effects Report #5655931-1
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Feb 21, 2008. Male patient, weighting 138.9 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: clostridial infection, diarrhoea, epistaxis, nausea
. Bevacizumab dosage: 1050 MG, Q3W. During the same period patient was treated with CARBOPLATIN, GEMCITABINE, CHLORPHENAMINE, CYCLIZINE, CODEINE SUL, ACETAMINOPHEN. Patient was hospitalized. Patient died.Bevacizumab Side Effects Report #5701286-3
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Mar 26, 2008. Male patient, weighting 138.9 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: circulatory collapse, diarrhoea, disease progression, peritonitis, sepsis
, vomiting. Bevacizumab dosage: 945 MG, Q3W. During the same period patient was treated with CARBOPLATIN, VINORELBINE, OMEPRAZOLE, NOVAMINSULFON, LAXOBERAL, MS CONTIN, SEVREDOL. Patient was hospitalized. Patient died on 06/01/2007.Bevacizumab Side Effects Report #5718497-3
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Apr 10, 2008. Male patient, weighting 180.3 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: aplasia pure red cell, dehydration, diarrhoea. Bevacizumab dosage: 15 MG/KG, Q3W. During the same period patient was treated with PACLITAXEL, CARBOPLATIN, BENIDIPINE, LOSARTAN POTASSIUM, AMLODIPINE BESYLATE. Patient recovered.
Bevacizumab Side Effects Report #5957365-9
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Nov 04, 2008. Female patient was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: diarrhoea, mucosal inflammation, neutrophil count decreased. Bevacizumab dosage: 15 MG/KG, Q3W. During the same period patient was treated with TAXOTERE, CISPLATIN, LEXAPRO, ELOCON. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5977890-4
Bevacizumab side effect was reported by a Physician from UNITED STATES on Nov 25, 2008. Male patient, weighting 174.0 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: acidosis, atrial fibrillation
, diarrhoea, sepsis , vomiting. Bevacizumab dosage: 10 MG/KG, UNK. During the same period patient was treated with PEMETREXED, GEMCITABINE. Patient was hospitalized. Patient died on 11/25/2008.Bevacizumab Side Effects Report #6049470-6
Bevacizumab side effect was reported by a Physician from UNITED STATES on Jan 16, 2009. Male patient, weighting 174.0 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: acidosis, atrial fibrillation
, diarrhoea, sepsis , vomiting. Bevacizumab dosage: 10 MG/KG, UNK. During the same period patient was treated with PEMETREXED, GEMCITABINE, LANOXIN, METOPROLOL TARTRATE, MAG OXIDE, PREDNISONE, ALPRAZOLAM, GLUCOSAMINE. Patient was hospitalized. Patient died on 11/25/2008.Bevacizumab Side Effects Report #6053888-5
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Jan 19, 2009. Male patient, weighting 216.0 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: arthralgia, diarrhoea, dysuria, hypophagia, nausea
, neutropenia, pyrexia. Bevacizumab dosage: unknown. During the same period patient was treated with CARBOPLATIN, PACLITAXEL. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #6055821-9
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Jan 16, 2009. Male patient, weighting 138.9 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: circulatory collapse, diarrhoea, disease progression, peritonitis, sepsis
, vomiting. Bevacizumab dosage: 945 MG, Q3W. During the same period patient was treated with CARBOPLATIN, VINORELBINE, OMEPRAZOLE, NOVAMINSULFON, LAXOBERAL, MS CONTIN, MORPHINE, ONDANSETRON. Patient was hospitalized. Patient died on 06/01/2007.Bevacizumab Side Effects Report #6092794-7
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Feb 10, 2009. Male patient, weighting 116.8 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: diarrhoea, platelet count decreased, white blood cell count decreased. Bevacizumab dosage: 875 MG, Q3W. During the same period patient was treated with PREDNISOLONE, VINORELBINE, CISPLATIN, DEXAVENT, SYNCUMAR, CODEINE, THIOCODIN, LANSOPRAZOLE. Patient was hospitalized. Patient died on 10/19/2007.
Bevacizumab Side Effects Report #6125904-3
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Mar 06, 2009. Male patient, weighting 116.8 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: diarrhoea, leukopenia, platelet count decreased. Bevacizumab dosage: 875 MG, Q3W. During the same period patient was treated with PREDNISOLONE, VINORELBINE, CISPLATIN, DEXAVENT, SYNCUMAR, CODEINE SUL, THIOCODIN, LANSOPRAZOLE. Patient was hospitalized. Patient died.
Bevacizumab Side Effects Report #5725795-6
Bevacizumab side effect was reported by a Physician from UNITED STATES on Apr 09, 2008. Female patient, weighting 220.0 lb, was diagnosed with neoplasm malignant and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: diarrhoea, dysphagia, feeding tube complication, infection
, nausea , oesophagitis, stomatitis. Bevacizumab dosage: 15 MG/KG, UNK. During the same period patient was treated with ERLOTINIB, PACLITAXEL, RADIATION. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5324283-9
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on May 04, 2007. Male patient, weighting 161.0 lb, was diagnosed with metastatic gastric cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain
, diarrhoea, hypokalaemia, mucosal inflammation, nausea . Bevacizumab dosage: 10 MG/KG, UNK. During the same period patient was treated with DOCETAXEL, CISPLATIN, IRINOTECAN, ATIVAN, COMPAZINE, DECADRON, FENTANYL, MIRALAX. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5328627-3
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on May 14, 2007. Male patient, weighting 161.0 lb, was diagnosed with metastatic gastric cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain
, diarrhoea, hypokalaemia, mucosal inflammation, nausea . Bevacizumab dosage: 10 MG/KG, UNK. During the same period patient was treated with DOCETAXEL, CISPLATIN, IRINOTECAN, ATIVAN, COMPAZINE, DECADRON, FENTANYL, MIRALAX. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5498601-5
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Oct 25, 2007. Male patient, weighting 174.2 lb, was diagnosed with metastatic gastric cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: diarrhoea, fatigue, febrile neutropenia, muscle spasms, nausea
, small intestinal obstruction. Bevacizumab dosage: 10MG/MG2 IV BOLUS. During the same period patient was treated with DOCETAXEL, CISPLATIN, IRINOTECAN. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5583934-4
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Jan 03, 2008. Male patient, weighting 174.2 lb, was diagnosed with metastatic gastric cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: diarrhoea, febrile neutropenia, ileus. Bevacizumab dosage: 10MG/M2 IV BOLUS. During the same period patient was treated with DOCETAXEL, CISPLATIN, IRINOTECAN. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5021746-0
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on May 22, 2006. Male patient, 67 years of age, weighting 250.0 lb, was diagnosed with insulinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, chills, dehydration, diarrhoea, fatigue, vomiting. Bevacizumab dosage: 570 MG, Q2W, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, LORAZEPAM, GRANISETRON, OXALIPLATIN, FLUOROURACIL, LEUCOVORIN CALCIUM, PROTONIX, SANDOSTATIN. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5330816-9
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on May 18, 2007. Male patient, 81 years of age, weighting 181.0 lb, was diagnosed with hepatic neoplasm malignant and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anorexia, chills, dehydration, diarrhoea, diverticulitis, hepatic mass, infection
, oral intake reduced. Bevacizumab dosage: 1567 MG IV Q 21 DAYS. During the same period patient was treated with ERLOTINIB, ASPIRIN, TOPROL, CLONIDINE, COZAAR, NORVASC, UNIRETIC, METFORMIN. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5879829-9
Bevacizumab side effect was reported by a Physician from UNITED STATES on Sept 05, 2008. Male patient, 56 years of age, was diagnosed with hepatic neoplasm malignant, hepatitis b
and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: diarrhoea, international normalised ratio increased, septic shock. Bevacizumab dosage: unknown. During the same period patient was treated with OXALIPLATIN, LANSOPRAZOLE, EPIVIR, SPIRONOLACTONE, CALCIUM. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #4724439-X
Bevacizumab side effect was reported by a Physician from UNITED STATES on July 22, 2005. Female patient, 51 years of age, weighting 197.0 lb, was diagnosed with hepatic neoplasm malignant and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: diarrhoea, enteritis, nausea
. Bevacizumab dosage: 10 MG/KG IV Q 2 WEEKS. During the same period patient was treated with GEMCITABINE, ALBUTEROL, CELEXA, COMPAZINE, GLYBURIDE, IBUPROFEN, LANCETS, LANTUS. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #6059941-4
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Jan 23, 2009. Male patient, weighting 148.6 lb, was diagnosed with hepatic neoplasm malignant and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: atrial flutter, cardiomyopathy
, diarrhoea, fatigue. Bevacizumab dosage: 10 MG/KG, Q2W. During the same period patient was treated with COMPAZINE, IMODIUM, OPIUM TINCTURE. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5815221-0
Bevacizumab side effect was reported by a Physician from UNITED STATES on July 11, 2008. Female patient, 53 years of age, weighting 180.8 lb, was diagnosed with glioblastoma multiforme, dyspnoea and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: diarrhoea, thrombosis, thrombotic microangiopathy. Bevacizumab dosage: 10 MG/KG, DAYS 1+15. During the same period patient was treated with IRINOTECAN, PROVENTIL, KEPPRA, ENALAPRIL MALEATE, PEPCID, DECADRON, EFFEXOR, NYSTATIN. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5046127-5
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on July 07, 2006. Male patient, weighting 207.2 lb, was diagnosed with glioblastoma multiforme and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: bacterial infection
, catheter related infection, diarrhoea, platelet count decreased, pyrexia, sepsis . Bevacizumab dosage: 947MG QOW IV. During the same period patient was treated with IRINOTECAN, DILANTIN. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5563578-0
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Dec 14, 2007. Male patient, weighting 141.1 lb, was diagnosed with glioblastoma multiforme and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: dehydration, diarrhoea, renal failure acute, urine output decreased. Bevacizumab dosage: 10MG/KG IV Q 2 WEEKS. During the same period patient was treated with TEMOZOLOMIDE, LEXAPRO, KEPPRA, DEPAKOTE ER, LORAZEPAM, GABAPENTIN, DECADRON, PRILOSEC. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5564290-4
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Dec 14, 2007. Male patient, weighting 141.1 lb, was diagnosed with glioblastoma multiforme and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: dehydration, diarrhoea, renal failure acute. Bevacizumab dosage: 10MG/KG IV Q 2 WEEKS. During the same period patient was treated with TEMOZOLOMIDE, LEXAPRO, DECADRON, KEPPRA, PRILOSEC, DEPAKOTE ER, LORAZEPAM, GABAPENTIN. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5879321-1
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Sept 10, 2008. Male patient, weighting 332.9 lb, was diagnosed with glioblastoma multiforme and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain
, diarrhoea, glioblastoma multiforme, ileus, malignant neoplasm progression, nausea , pyrexia, small intestinal obstruction. Bevacizumab dosage: unknown. During the same period patient was treated with BORTIZOMIB, PROVIGIL, TRAZODONE, KEPPRA. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #4799983-X
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Oct 11, 2005. Male patient, 69 years of age, weighting 194.3 lb, was diagnosed with gastrooesophageal cancer, metastasis and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: diarrhoea, fall
, fatigue, haemoglobin decreased. Bevacizumab dosage: 15MG/KG IV EVERY 21 DAY. During the same period patient was treated with OXALIPLATIN, DOCETAXEL, FERROUS SULPHATE, MOTRIN. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5752668-5
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on May 27, 2008. Male patient, 57 years of age, weighting 166.7 lb, was diagnosed with gastrointestinal disorder and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: dehydration, diarrhoea, febrile neutropenia. Bevacizumab dosage: unknown. During the same period patient was treated with DOCETAXEL, OXALIPLATIN. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5474974-4
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Sept 20, 2007. Male patient was diagnosed with gastric cancer, pain
and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: diarrhoea, skin disorder. Bevacizumab dosage: 450 MG, Q2W. During the same period patient was treated with ERLOTINIB, DURAGESIC, ACETAMINOPHEN, MORPHINE. Patient died on 09/10/2007.Bevacizumab Side Effects Report #4694820-6
Bevacizumab side effect was reported by a Health Professional from on June 06, 2005. Female patient, 81 years of age, weighting 129.0 lb, was diagnosed with colorectal cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: acute prerenal failure, bacteria urine identified, blood calcium decreased, blood potassium decreased, diarrhoea, electrolyte imbalance, fatigue, gram stain positive, hyperglycaemia. Bevacizumab dosage: 10 MG/KG, Q2W, INTRAVENOUS. During the same period patient was treated with CAPECITABINE, OXALIPLATIN, CLARITIN, VITAMIN, IRON. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #4822901-2
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Oct 25, 2005. Female patient, 81 years of age, weighting 129.0 lb, was diagnosed with colorectal cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: acute prerenal failure, blood calcium decreased, blood potassium decreased, diarrhoea, electrolyte imbalance, fatigue, gram stain positive, hyperglycaemia, hypotension. Bevacizumab dosage: 10 MG/KG, Q2W, INTRAVENOUS. During the same period patient was treated with CAPECITABINE, OXALIPLATIN, CLARITIN, VITAMIN, IRON. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #4799681-2
Bevacizumab side effect was reported by a Health Professional from ITALY on Sept 21, 2005. Female patient, 63 years of age, weighting 101.4 lb, was diagnosed with colorectal cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood sodium decreased, diarrhoea, nausea
, pyrexia. Bevacizumab dosage: 345 MG, Q3W, INTRAVENOUS. During the same period patient was treated with CAPECITABINE, IRINOTECAN, ESOMEPRAZOLE. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5300552-3
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Apr 10, 2007. Male patient, weighting 142.0 lb, was diagnosed with colorectal cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: diarrhoea, oedema peripheral, pleural effusion, vomiting. Bevacizumab dosage: 330 MG, QOW. During the same period patient was treated with CETUXIMAB, FLUOROURACIL, LEUCOVORIN CALCIUM, FOSAMAX, ZOCOR, ENALAPRIL MALEATE, AMARYL. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5308442-7
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Apr 18, 2007. Male patient, weighting 142.0 lb, was diagnosed with colorectal cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: arteriosclerosis, atelectasis, blood potassium decreased, diarrhoea, hepatic mass, oedema peripheral, osteoporosis
, pericardial effusion. Bevacizumab dosage: 330 MG, QOW. During the same period patient was treated with CETUXIMAB, FLUOROURACIL, LEUCOVORIN CALCIUM, FOSAMAX, ZOCOR, ENALAPRIL MALEATE, AMARYL. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5320578-3
Bevacizumab side effect was reported by a Physician from UNITED STATES on May 02, 2007. Male patient, weighting 142.0 lb, was diagnosed with colorectal cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: arteriosclerosis, atelectasis, capillary leak syndrome, congestive cardiomyopathy, diarrhoea, fluid overload, gastroenteritis
, haematocrit decreased. Bevacizumab dosage: 330 MG, QOW. During the same period patient was treated with CETUXIMAB, FLUOROURACIL, LEUCOVORIN CALCIUM, FOSAMAX, ZOCOR, ENALAPRIL, AMARYL. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5333448-1
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on May 09, 2007. Male patient was diagnosed with colorectal cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: diarrhoea, intestinal obstruction, nausea
. Bevacizumab dosage: 7.5 MG/M2, Q3W. During the same period patient was treated with CAPECITABINE, MITOMYCIN. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5354593-0
Bevacizumab side effect was reported by a Physician from UNITED STATES on June 05, 2007. Male patient, weighting 142.0 lb, was diagnosed with colorectal cancer metastatic, osteoporosis
, blood cholesterol, blood pressure , diabetes mellitus and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: diarrhoea, oedema peripheral, pleural effusion, vomiting. Bevacizumab dosage: 330 MG, QOW. During the same period patient was treated with CETUXIMAB, FLUOROURACIL, LEUCOVORIN CALCIUM, FOSAMAX, ZOCOR, ENALAPRIL MALEATE, AMARYL. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5395582-X
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on July 09, 2007. Male patient was diagnosed with colorectal cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: diarrhoea, intestinal obstruction, nausea
. Bevacizumab dosage: 7.5 MG/M2, Q3W. During the same period patient was treated with CAPECITABINE, MITOMYCIN. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5431730-0
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Aug 16, 2007. Male patient was diagnosed with colorectal cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anorexia, asthenia, blood creatinine increased, blood urea increased, diarrhoea, musculoskeletal chest pain, nausea
, weight decreased. Bevacizumab dosage: 570 MG, Q3W. During the same period patient was treated with CAPECITABINE, IRINOTECAN, KETOPROFEN, LYTOS, TRAMADOL. Patient died on 08/09/2007.Bevacizumab Side Effects Report #5450440-7
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Aug 30, 2007. Female patient, weighting 138.9 lb, was diagnosed with colorectal cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: diarrhoea, lethargy, nausea
, renal failure acute, urinary tract infection . Bevacizumab dosage: 7.5 MG/KG, Q3W. During the same period patient was treated with CAPECITABINE, MITOMYCIN, FLUCLOXACILLIN. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5478664-3
Bevacizumab side effect was reported by a Consumer or non-health professional from SWITZERLAND on Sept 20, 2007. Male patient, weighting 209.9 lb, was diagnosed with colorectal cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: dehydration, diarrhoea, hypertension, lethargy, pyrexia. Bevacizumab dosage: 475 MG, Q2W. During the same period patient was treated with FLUOROURACIL, FOLINIC ACID, ONDANSETRON. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5529681-6
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Nov 21, 2007. Male patient, weighting 149.9 lb, was diagnosed with colorectal cancer metastatic, hypertension and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: asthenia, diarrhoea, gastrointestinal haemorrhage, renal failure. Bevacizumab dosage: 385 MG, UNK. During the same period patient was treated with IRINOTECAN, FLUOROURACIL, FOLINIC ACID, RAMIPRIL. Patient recovered.
Bevacizumab Side Effects Report #5535651-4
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Nov 23, 2007. Female patient, weighting 149.9 lb, was diagnosed with colorectal cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: diarrhoea, gastritis, nausea
. Bevacizumab dosage: 510 MG, Q3W. During the same period patient was treated with CAPECITABINE, MITOMYCIN C. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5616166-1
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Jan 25, 2008. Male patient, weighting 169.8 lb, was diagnosed with colorectal cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: diarrhoea, hypokalaemia, pyrexia. Bevacizumab dosage: unknown. During the same period patient was treated with CAPECITABINE, OXALIPLATIN, TEBETANE COMPUESTO, OMEPRAZOLE. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5641710-8
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Feb 20, 2008. Male patient was diagnosed with colorectal cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: diarrhoea, nausea
. Bevacizumab dosage: 7.5 MG/M2, Q3W. During the same period patient was treated with CAPECITABINE, MITOMYCIN. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5810724-7
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on June 16, 2008. Female patient was diagnosed with colorectal cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: diarrhoea, nausea
. Bevacizumab dosage: 255 MG, Q2W. During the same period patient was treated with OXALIPLATIN, CAPECITABINE, CODEINE SUL, ACETAMINOPHEN, TYLENOL. Patient was hospitalized. Patient died on 06/07/2008.Bevacizumab Side Effects Report #5840767-9
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on July 28, 2008. Female patient was diagnosed with colorectal cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: diarrhoea, fatigue, pyrexia. Bevacizumab dosage: unknown. During the same period patient was treated with ERLOTINIB. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5845809-2
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on July 31, 2008. Female patient, weighting 149.9 lb, was diagnosed with colorectal cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: diarrhoea, gastritis, nausea
. Bevacizumab dosage: 4000 MG, D1-14/Q3W. During the same period patient was treated with CAPECITABINE, MITOMYCIN, LOPERAMIDE, MICARDIS, TEMAZEPAM. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5934786-1
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Oct 14, 2008. Male patient, weighting 127.6 lb, was diagnosed with colorectal cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: diarrhoea, palmar-plantar erythrodysaesthesia syndrome, pigmentation disorder, rash
, stomatitis. Bevacizumab dosage: 310 MG, Q2W. During the same period patient was treated with IRINOTECAN HYDROCHLORIDE, GRANISETRON. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5957424-0
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Nov 06, 2008. Female patient, weighting 132.3 lb, was diagnosed with colorectal cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anorexia, blood bilirubin increased, creatinine renal clearance decreased, dehydration, diarrhoea, fatigue, nausea
, platelet count increased. Bevacizumab dosage: 450 MG, Q3W. During the same period patient was treated with CAPECITABINE, ASPIRIN. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5960684-3
Bevacizumab side effect was reported by a Physician from DENMARK on Nov 05, 2008. Female patient was diagnosed with colorectal cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: diarrhoea, infection
, pharyngeal inflammation, pyrexia, weight decreased. Bevacizumab dosage: 7.5 MG/KG, Q3W. During the same period patient was treated with OXALIPLATIN, LEUCOVORIN CALCIUM, FLUOROURACIL. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5975893-7
Bevacizumab side effect was reported by a Physician from DENMARK on Nov 17, 2008. Female patient was diagnosed with colorectal cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: diarrhoea, infection
, musculoskeletal pain, pharyngeal inflammation, pyrexia, weight decreased. Bevacizumab dosage: 7.5 MG/KG, Q3W. During the same period patient was treated with OXALIPLATIN, LEUCOVORIN CALCIUM, FLUOROURACIL. Patient recovered.Bevacizumab Side Effects Report #5978062-X
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Nov 20, 2008. Male patient, weighting 127.6 lb, was diagnosed with colorectal cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: diarrhoea, rash
, stomatitis. Bevacizumab dosage: 310 MG, Q2W. During the same period patient was treated with IRINOTECAN, GRANISETRON. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5994508-5
Bevacizumab side effect was reported by a Physician from DENMARK on Nov 28, 2008. Female patient was diagnosed with colorectal cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: diarrhoea, infection
, intestinal perforation, pharyngeal inflammation, pyrexia, weight decreased. Bevacizumab dosage: 7.5 MG/KG, Q3W. During the same period patient was treated with OXALIPLATIN, LEUCOVORIN CALCIUM, FLUOROURACIL. Patient recovered.Bevacizumab Side Effects Report #6036340-2
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Jan 08, 2008. Male patient, weighting 175.0 lb, was diagnosed with colorectal cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: diarrhoea. Bevacizumab dosage: 630 MG, Q3W. During the same period patient was treated with OXALIPLATIN, CAPECITABINE, METFORMIN, ACTOS, LIPITOR, LISINOPRIL, COMPAZINE. Patient died on 01/06/2008.
Bevacizumab Side Effects Report #5007480-1
Bevacizumab side effect was reported by a Physician from UNITED STATES on May 15, 2006. Female patient, 81 years of age, weighting 129.0 lb, was diagnosed with colorectal cancer
and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: acute prerenal failure, blood calcium decreased, blood potassium decreased, dehydration, diarrhoea, electrolyte imbalance, fatigue, hyperglycaemia, hypotension. Bevacizumab dosage: 10 MG/KG, Q2W, INTRAVENOUS. During the same period patient was treated with CAPECITABINE, OXALIPLATIN, CLARITIN, VITAMIN, IRON. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5283868-9
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Mar 19, 2007. Female patient, 63 years of age, was diagnosed with colorectal cancer
and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: diarrhoea, infection , sepsis . Bevacizumab dosage: 450 MG, UNK. During the same period patient was treated with CAPECITABINE, IRINOTECAN. Patient was hospitalized. Patient died on 03/19/2007.Bevacizumab Side Effects Report #5174214-X
Bevacizumab side effect was reported by a Physician from UNITED STATES on Nov 22, 2006. Male patient, 61 years of age, weighting 177.3 lb, was diagnosed with colorectal cancer
and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: blood alkaline phosphatase increased, diarrhoea, hypokalaemia, hypomagnesaemia, hyponatraemia, hypophosphataemia, intestinal obstruction, nausea . Bevacizumab dosage: 5 MG/KG, Q2W, INTRAVENOUS. During the same period patient was treated with OXALIPLATIN, ATENOLOL, PLAVIX, DIOVAN, COMPAZINE, IMODIUM, VITAMIN B, FOLIC ACID. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5198024-2
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Dec 19, 2006. Male patient, 61 years of age, weighting 177.3 lb, was diagnosed with colorectal cancer
and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: adhesion , diarrhoea, hypokalaemia, hypomagnesaemia, hyponatraemia, hypophosphataemia, intestinal obstruction, metastases to peritoneum, nausea . Bevacizumab dosage: 5 MG/KG, Q2W, INTRAVENOUS. During the same period patient was treated with OXALIPLATIN, CAPECITABINE, ATENOLOL, PLAVIX, DIOVAN, COMPAZINE, IMODIUM, VITAMIN B. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5311630-7
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Apr 27, 2007. Male patient was diagnosed with colorectal cancer
and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abscess , diarrhoea, pyrexia. Bevacizumab dosage: 600 MG, Q3W. During the same period patient was treated with CAPECITABINE, OXALIPLATIN, MARCUMAR, SOTALOL HYDROCHLORIDE, IBUPROFEN. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5322518-X
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Apr 26, 2007. Male patient was diagnosed with colorectal cancer
and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: dehydration, diarrhoea, fistula , hypokalaemia. Bevacizumab dosage: 525 MG, Q3W. During the same period patient was treated with CAPECITABINE, OXALIPLATIN, LOPERAMIDE. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5474860-X
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Sept 17, 2007. Male patient was diagnosed with colorectal cancer
and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: diarrhoea, pulmonary embolism . Bevacizumab dosage: 560 MG, QD. During the same period patient was treated with CAPECITABINE, OXALIPLATIN, CETUXIMAB, ASCAL, SELEKTINE, FOSINOPRIL. Patient was hospitalized. Patient died on 12/15/2006.Bevacizumab Side Effects Report #5586782-4
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Dec 27, 2007. Male patient was diagnosed with colorectal cancer
and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: dehydration, diarrhoea, pain , pyrexia. Bevacizumab dosage: 5 MG/KG, Q2W. During the same period patient was treated with CAPECITABINE, OXALIPLATIN, COZAAR, METFORMIN, ATENOLOL, CIPRO, LOVASTATIN. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5655231-X
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Feb 25, 2008. Male patient, weighting 202.8 lb, was diagnosed with colorectal cancer
and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: diarrhoea. Bevacizumab dosage: 700 MG, Q3W. During the same period patient was treated with CAPECITABINE, OXALIPLATIN. Patient was hospitalized. Patient died on 12/31/2007.Bevacizumab Side Effects Report #5660915-3
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Feb 27, 2008. Male patient was diagnosed with colorectal cancer
and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: dehydration, diarrhoea, pain , pyrexia. Bevacizumab dosage: 5 MG/KG, Q2W. During the same period patient was treated with CAPECITABINE, OXALIPLATIN, COZAAR, METFORMIN, ATENOLOL, CIPRO, LOVASTATIN. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5926996-4
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Oct 10, 2008. Female patient was diagnosed with colorectal cancer
and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: dehydration, diarrhoea, hypovolaemic shock. Bevacizumab dosage: 7.5 MG/KG, UNK. During the same period patient was treated with CETUXIMAB, OXALIPLATIN, IRINOTECAN HYDROCHLORIDE, FLUOROURACIL, LEUCOVORIN CALCIUM. Patient recovered.Bevacizumab Side Effects Report #5958774-4
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Nov 04, 2008. Female patient was diagnosed with colorectal cancer
and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: dehydration, diarrhoea, hypotension, pyrexia. Bevacizumab dosage: 5 MG/KG, Q2W. During the same period patient was treated with OXALIPLATIN, LEUCOVORIN CALCIUM, FLUOROURACIL. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5966855-4
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Nov 12, 2008. Male patient was diagnosed with colorectal cancer
and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: blood creatinine increased, dehydration, diarrhoea, hypokalaemia, renal failure. Bevacizumab dosage: 7.5 MG/KG, UNK. During the same period patient was treated with OXALIPLATIN, FLUOROURACIL, LEUCOVORIN CALCIUM, CETUXIMAB, IRINOTECAN HYDROCHLORIDE. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #6008982-1
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Sept 17, 2007. Male patient was diagnosed with colorectal cancer
and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: diarrhoea, pneumothorax, pulmonary embolism . Bevacizumab dosage: 560 MG, Q3W. During the same period patient was treated with CAPECITABINE, OXALIPLATIN, CETUXIMAB, ASCAL, SELEKTINE, FOSINOPRIL. Patient was hospitalized. Patient died on 12/15/2006.Bevacizumab Side Effects Report #6028916-3
Bevacizumab side effect was reported by a Physician from GREECE on Dec 23, 2008. Female patient was diagnosed with colorectal cancer
and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: biliary cirrhosis primary, cardiac failure, cardiotoxicity, diarrhoea, disease progression, hepatic failure, mucosal inflammation, nausea , pancytopenia. Bevacizumab dosage: 7.5 MG/KG, Q21D. During the same period patient was treated with CAPECITABINE, IRINOTECAN, DEXAMETHASONE, ATROPINE, TACROLIMUS. Patient died.Bevacizumab Side Effects Report #4990612-9
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on May 01, 2006. Male patient, weighting 160.3 lb, was diagnosed with colorectal cancer
and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: colitis, dehydration, diarrhoea, neutrophil count decreased, white blood cell count decreased. Bevacizumab dosage: 364 MG. During the same period patient was treated with CAMPTOSAR. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5534770-6
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Nov 21, 2007. Female patient was diagnosed with colon cancer recurrent and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: diarrhoea, renal impairment, vomiting. Bevacizumab dosage: 5 MG/KG, UNK. During the same period patient was treated with FLUOROURACIL, ISOVORIN, IRINOTECAN, OXYCONTIN, NORVASC. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5635044-5
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Feb 08, 2008. Female patient was diagnosed with colon cancer recurrent and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: diarrhoea, renal impairment, vomiting. Bevacizumab dosage: 5 MG/KG, UNK. During the same period patient was treated with FLUOROURACIL, ISOVORIN, IRINOTECAN, OXYCONTIN, NORVASC. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5746946-3
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on May 12, 2008. Female patient was diagnosed with colon cancer recurrent and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: diarrhoea, renal impairment, vomiting. Bevacizumab dosage: 5 MG/KG, UNK. During the same period patient was treated with FLUOROURACIL, ISOVORIN, IRINOTECAN, OXYCONTIN, NORVASC. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5315565-5
Bevacizumab side effect was reported by a Pharmacist from UNITED STATES on Apr 30, 2007. Male patient, 85 years of age, weighting 193.6 lb, was diagnosed with colon cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: aspiration, diarrhoea, dyspnoea, hypotension, ileus, malaise, myocardial infarction, nausea
, pneumatosis. Bevacizumab dosage: 700 MG ONCE IV. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5585789-0
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Dec 26, 2007. Female patient, 73 years of age, weighting 127.9 lb, was diagnosed with colon cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: diarrhoea, renal failure acute. Bevacizumab dosage: 5 MG/KG, QD. During the same period patient was treated with OXALIPLATIN, FLUOROURACIL, ISOVORIN. Patient recovered.
Bevacizumab Side Effects Report #5637304-0
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Feb 13, 2008. Female patient, 73 years of age, weighting 127.9 lb, was diagnosed with colon cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: diarrhoea, renal failure acute. Bevacizumab dosage: 5 MG/KG, QD. During the same period patient was treated with OXALIPLATIN, FLUOROURACIL, ISOVORIN. Patient recovered.
Bevacizumab Side Effects Report #5663471-9
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Mar 03, 2008. Female patient, 73 years of age, weighting 127.9 lb, was diagnosed with colon cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: diarrhoea, renal failure acute. Bevacizumab dosage: 5 MG/KG, Q2W. During the same period patient was treated with OXALIPLATIN, FLUOROURACIL, ISOVORIN. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5215801-X
Bevacizumab side effect was reported by a Pharmacist from UNITED STATES on Jan 08, 2007. Female patient, 54 years of age, weighting 140.9 lb, was diagnosed with colon cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain
, atelectasis, blood bilirubin increased, cardiac arrest , diarrhoea, dyspnoea, hepatic necrosis, hepatic steatosis, intestinal ischaemia. Bevacizumab dosage: 640 MG, Q3W, INTRAVENOUS. During the same period patient was treated with XELODA, DARVOCET, PHENERGAN, PROPOFOL. Patient was hospitalized. Patient died on 11/30/2006.Bevacizumab Side Effects Report #5595700-4
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Jan 04, 2008. Male patient was diagnosed with colon cancer metastatic, colorectal cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: diarrhoea, partial seizures. Bevacizumab dosage: 975 MG, Q3W. During the same period patient was treated with XELODA, MITOMYCIN. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #6056962-2
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Jan 22, 2009. Female patient, 60 years of age, weighting 140.2 lb, was diagnosed with colon cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: diarrhoea, ileitis. Bevacizumab dosage: 5 MG/M2, Q14D. During the same period patient was treated with OXALIPLATIN, CAPECITABINE. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #6076080-7
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Feb 04, 2009. Female patient, 60 years of age, weighting 140.2 lb, was diagnosed with colon cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: diarrhoea, ileitis. Bevacizumab dosage: 5 MG/M2, Q14D. During the same period patient was treated with OXALIPLATIN, CAPECITABINE, IMODIUM. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #6084464-6
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Feb 11, 2009. Female patient, 60 years of age, weighting 140.2 lb, was diagnosed with colon cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: diarrhoea, ileitis. Bevacizumab dosage: 5 MG/M2, Q14D. During the same period patient was treated with OXALIPLATIN, CAPECITABINE, IMODIUM. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #6106001-X
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Feb 26, 2009. Female patient, 60 years of age, weighting 140.2 lb, was diagnosed with colon cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: diarrhoea, ileitis. Bevacizumab dosage: 5 MG/M2, Q14D. During the same period patient was treated with OXALIPLATIN, CAPECITABINE, IMODIUM. Patient was hospitalized. Patient recovered.